Transplant International | New and Recent Articles https://www.frontierspartnerships.org/journals/transplant-international RSS Feed for Transplant International | New and Recent Articles en-us Frontiers Feed Generator,version:1 2026-10-01T07:50:00.08+00:00 60 https://www.frontierspartnerships.org/articles/10.3389/ti.2026.16893 https://www.frontierspartnerships.org/articles/10.3389/ti.2026.16893 <![CDATA[The frequency and timing of leukopenia and CMV infections in kidney transplant recipients in Finland – a retrospective observational study]]> 2026-10-01T00:00:00Z Original Research Ilkka HelanteräFernanda OrtizEssi HavulaSamuli TuominenMarkus HakamäkiTapio HellmanSatu MäkeläRiku Korhonen https://www.frontierspartnerships.org/articles/10.3389/ti.2026.17165 https://www.frontierspartnerships.org/articles/10.3389/ti.2026.17165 <![CDATA[Disparities in outcomes among patients on lung transplantation waitlist in Saudi Arabia]]> 2026-10-01T00:00:00Z Letter to the Editor Amjad AlbatliRuqayyah FadhelYehia Rabea YousefRana Ahmed SalehHaifa AldakhilYasmin AltwaijriFaisal AlbaizKhaled AlkattanWaleed SalehMoheeb AlawwamiAmer AlzahraniHusna ThalibBedour AlmudaiheemKris MarquezRayid Abdulqawi https://www.frontierspartnerships.org/articles/10.3389/ti.2026.17855 https://www.frontierspartnerships.org/articles/10.3389/ti.2026.17855 <![CDATA[Guiding light: new European guidelines on CLAD prevention and treatment]]> 2026-09-30T00:00:00Z Forum Kieran Halloran https://www.frontierspartnerships.org/articles/10.3389/ti.2026.17554 https://www.frontierspartnerships.org/articles/10.3389/ti.2026.17554 <![CDATA[Decoding AI for transplantation: many models, one patient: why there is no single “AI for transplantation” – and what to ask instead]]> 2026-09-30T00:00:00Z Special Article Olivier AubertEsteban Cortes GarciaSilvia PinedaThomas NeyensNina Pilat https://www.frontierspartnerships.org/articles/10.3389/ti.2026.17772 https://www.frontierspartnerships.org/articles/10.3389/ti.2026.17772 <![CDATA[Correction: Landscape of current practices and future perspectives in living donor kidney donation in Europe: proceedings of a pan-European symposium by the European kidney transplant association section of the European Society for Organ Transplantation]]> 2026-09-28T00:00:00Z Correction Transplant International Production Office https://www.frontierspartnerships.org/articles/10.3389/ti.2026.16322 https://www.frontierspartnerships.org/articles/10.3389/ti.2026.16322 <![CDATA[Nutritional strategies in kidney transplantation: optimising outcomes beyond surgery]]> 2026-09-24T00:00:00Z Review Lara CaldiroliPaolo MolinariSimone VettorettiAnna RegaliaSimona VerdescaGiuseppe CastellanoMaurizio GallieniCarlo Alfieri https://www.frontierspartnerships.org/articles/10.3389/ti.2026.16702 https://www.frontierspartnerships.org/articles/10.3389/ti.2026.16702 <![CDATA[Bortezomib in combination with standard-of-care for late active antibody-mediated rejection with de novo donor-specific antibodies after kidney transplantation: a multicenter randomized trial]]> 2026-09-23T00:00:00Z Original Research Renaud SnanoudjFabienne MarquantKarine RenaudinValérie DuboisAlice KoenigNadia ArzoukSophie CaillardMagali GiralArwa Jalal EddineHakim MazouzNassim KamarVincent PerninMarie MatignonNacera OualiDany AnglicheauCaroline Elie 50% reduction in immunodominant DSA mean fluorescence intensity and stabilization or improvement of microvascular inflammation and transplant glomerulopathy on graft biopsy at 12 months. This endpoint was achieved in 40.0% of patients receiving bortezomib and 33.3% receiving standard-of-care alone in the intention-to-treat analysis (RR = 1.20, 95% CI 0.61–2.34; p = 0.59), and in 50.0% and 42.1%, respectively, in the per-protocol analysis (RR = 1.19, 95% CI 0.60–2.36; p = 0.62). Neither component differed between groups. Serious adverse events occurred in 23 patients (76.7%) receiving bortezomib and 14 patients (46.7%) receiving standard-of-care alone (p = 0.017). Adding bortezomib did not demonstrate a significant efficacy benefit and was associated with a higher incidence of serious adverse events (ClinicalTrials.gov number: NCT02201576).]]> https://www.frontierspartnerships.org/articles/10.3389/ti.2026.16175 https://www.frontierspartnerships.org/articles/10.3389/ti.2026.16175 <![CDATA[Evolution and interrelation of physical frailty and mild cognitive impairment up to two years after kidney transplantation: a multi-center prospective cohort study]]> 2026-09-21T00:00:00Z Original Research Nadine BeerliManuel WehrleIsabelle BinetMichael DickenmannDéla GolshayanKarine HadayaUyen Huynh-DoReto W. KressigSabina De GeestOliver Mauthner https://www.frontierspartnerships.org/articles/10.3389/ti.2026.17154 https://www.frontierspartnerships.org/articles/10.3389/ti.2026.17154 <![CDATA[Normothermic regional perfusion in controlled donation after circulatory death liver transplantation: an updated systematic review and meta-analysis versus non-NRP and brain-death donors]]> 2026-09-21T00:00:00Z Systematic Review and Meta-Analysis José Ramírez‐EstebanEzequiel SarrióAlberto Ruiz‐PachecoAna CotsNekane Romero‐GarcíaRafael Badenes https://www.frontierspartnerships.org/articles/10.3389/ti.2026.17151 https://www.frontierspartnerships.org/articles/10.3389/ti.2026.17151 <![CDATA[The INTEGRITY guidelines – ethical guidance for research involving deceased donation and transplantation]]> 2026-09-18T00:00:00Z Guidelines Dominique E. MartinAli AbbasiRiadh A. S. FadhilJohn L. R. ForsytheMatthieu Le DorzeJayme E. LockeElmi MullerGabriel C. OniscuHelen OpdamKaren RockellMarion J. SiebelinkShih-Ning ThenEmma Tumilty https://www.frontierspartnerships.org/articles/10.3389/ti.2026.16959 https://www.frontierspartnerships.org/articles/10.3389/ti.2026.16959 <![CDATA[European society for organ transplantation clinical practice guideline on prevention and treatment of chronic lung allograft dysfunction]]> 2026-09-18T00:00:00Z Guidelines Saskia BosMerel HellemonsKavita DaveMaarten F. M. EngelAre HolmLetizia MorlacchiVeronika MüllerStefano PavanelloClément PicardVeronica RossiBerta Saez-GimenezJens GottliebRobin Vos https://www.frontierspartnerships.org/articles/10.3389/ti.2026.16664 https://www.frontierspartnerships.org/articles/10.3389/ti.2026.16664 <![CDATA[Five years after introduction of an opt-out consent system for organ donation; lessons learned from England and the Netherlands]]> 2026-09-15T00:00:00Z Original Research Nichon Esther JansenTineke Jentina WindMartin B. A. HeemskerkAline C. HemkeClaire WillimentSue MaddenDale Gardiner https://www.frontierspartnerships.org/articles/10.3389/ti.2026.16585 https://www.frontierspartnerships.org/articles/10.3389/ti.2026.16585 <![CDATA[Developing European policy on xenotransplantation: instructive findings from the first representative UK sample survey on attitudes and views on animal to human transplants]]> 2026-09-15T00:00:00Z Original Research Mustafa Al-HaboubiPaul BoaduAgata PachoNicholas MaysAntonia J. Cronin https://www.frontierspartnerships.org/articles/10.3389/ti.2026.16452 https://www.frontierspartnerships.org/articles/10.3389/ti.2026.16452 <![CDATA[Organ donation after euthanasia starting at home: a mixed-methods study of preliminary nationwide Dutch experiences]]> 2026-09-14T00:00:00Z Original Research Isabelle MandersNathalie van DijkJohan SonneveldWim de JonghJan BollenNichon E. JansenWalther van Mook https://www.frontierspartnerships.org/articles/10.3389/ti.2026.15874 https://www.frontierspartnerships.org/articles/10.3389/ti.2026.15874 <![CDATA[Multi-site cytokine levels are predictive of primary graft dysfunction following lung transplantation]]> 2026-09-14T00:00:00Z Original Research Dianna NordJason Cory BrunsonLogan LangerudeHassan MoussaBlake GillMindaugas RackauskasAshish SharmaChristine LinAmir EmtiazjooCarl Atkinson https://www.frontierspartnerships.org/articles/10.3389/ti.2026.16366 https://www.frontierspartnerships.org/articles/10.3389/ti.2026.16366 <![CDATA[Abatacept as maintenance therapy in kidney transplantation: a retrospective comparative study]]> 2026-09-14T00:00:00Z Original Research Charlotte Uro-CosteInès RamosAurélien TipleMarine FreistClaire ChatronAlba AtenzaJimmy GarraudClarisse GrèzeCarole PhilipponnetPaul RouzaireAnne-elisabeth HengCyril Garrouste 0.999). Rates of viral and opportunistic infections were also comparable. These findings, which warrant confirmation in larger studies, suggest that abatacept is associated with acceptable safety outcomes relative to belatacept. Abatacept may thererefore be considered a potential alternative in selected situations, including drug shortage, limited venous access, pregnancy or the need for greater treatment autonomy.]]> https://www.frontierspartnerships.org/articles/10.3389/ti.2026.17609 https://www.frontierspartnerships.org/articles/10.3389/ti.2026.17609 <![CDATA[Reshaping the landscape of HLA desensitization through immune engineering]]> 2026-09-14T00:00:00Z News and Views Delphine KervellaOriol Bestard https://www.frontierspartnerships.org/articles/10.3389/ti.2026.17124 https://www.frontierspartnerships.org/articles/10.3389/ti.2026.17124 <![CDATA[Whole pediatric liver graft in modified RAPID transplantation for unresectable colorectal liver metastases]]> 2026-09-10T00:00:00Z Brief Research Report Roberto Luca MeniconiNicola GuglielmoMaria LanzoneFrancesca MazzarottoMarco ColasantiGiammauro BerardiMarco AngrisaniGermano MarianoDavide ChiapporiEleonora GarofaloGiuseppe Maria Ettorre https://www.frontierspartnerships.org/articles/10.3389/ti.2026.17050 https://www.frontierspartnerships.org/articles/10.3389/ti.2026.17050 <![CDATA[Donor-derived viral infections: the usual suspects and the new kids on the block]]> 2026-09-10T00:00:00Z Review Maddalena PeghinPaolo Antonio Grossi https://www.frontierspartnerships.org/articles/10.3389/ti.2026.16427 https://www.frontierspartnerships.org/articles/10.3389/ti.2026.16427 <![CDATA[Locus-specific HLA matching and induction therapy in simultaneous pancreas–kidney transplantation: a national UK cohort study]]> 2026-09-09T00:00:00Z Original Research Abdullah K. MalikJenni BanksClaire CounterLewis SimmondsSamuel J. TingleSanjay SinhaAnand MuthasamyAndrew SutherlandJohn CaseyMartin DrageDavid van DellenChris J. CallaghanDoruk ElkerDerek M. ManasGavin J. PettigrewNeil RussellNeil S. SheerinColin H. WilsonSteven A. White